Maine court lets drugmakers and PhRMA join the 340B rebate suit
Issue
On October 22, 2026, the Maine federal court let AbbVie, Pharmacyclics, Bristol-Myers Squibb, Boehringer Ingelheim and PhRMA join the hospitals’ lawsuit against the 340B rebate pilot. The hospitals opposed their entry and the government took no position.
The pilot is set to start January 1, 2027.
Sources for this story
U.S. District Court, District of Maine — American Hospital Association v. Kennedy, No. 1:26-cv-00515, Dkt. 49 (order on motions to intervene), via CourtListenerSources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
Part of
- 340B drug pricing
HRSA's rebate model pilot
FQHC Talent. (2026, October 22). Maine court lets drugmakers and PhRMA join the 340B rebate suit. Source: U.S. District Court, District of Maine — American Hospital Association v. Kennedy, No. 1:26-cv-00515, Dkt. 49 (order on motions to intervene), via CourtListener. Retrieved October 27, 2026, from https://www.fqhctalent.com/intel/aha-v-kennedy-court-grants-intervention-340b-rebate-pilot-october-2026
More in Legislation
Oct 23
Texas HHSC to amend CHIP state plan for new immigrant eligibility limits
Oct 22
Boston court hears work rule case and will rule in coming weeks
Oct 20
Patients and physician groups ask Maryland court to strike down frailty limits
Oct 19
Court sets summary judgment dates in states’ suit over 2027 marketplace rule